EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeted nanotherapy for kidney diseases: a comprehensive review

Gianmarco Sabiu iD, Vivek Kasinath, Sungwook Jung, Xiaofei Li, George C Tsokos, Reza Abdi

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfac233 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Gianmarco Sabiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Kidney Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney diseases represent a major public health problem, affecting millions of people worldwide. Moreover, the treatment of kidney diseases is burdened by the problematic effects of conventional drug delivery, such as systemic drug toxicity, rapid drug clearance, and the absence of precise targeting of the kidney. Although the use of nanotechnology in medicine is in its early stage and lacks robust translational studies, nanomedicines have already shown great promise as novel drug-delivery systems for the treatment of kidney disease. On the basis of our current knowledge of renal anatomy and physiology, pathophysiology of kidney diseases, and physicochemical characteristics of nanoparticles, an expansive repertoire and wide use of nanomedicines could be developed for kidney diseases in the near future. Some limitations have slowed the transition of these agents from preclinical studies to clinical trials, however. In this review, we summarize the current knowledge on renal drug-delivery systems and recent advances in renal cell targeting; we also demonstrate their important potential as future paradigm-shifting therapies for kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney DiseasesHumansDrug Delivery SystemsNanomedicinePharmaceutical PreparationsKidney

Stichwörter der Autor:innen

drug deliverynanomedicinenanoparticlesrenal drug deliverytarget therapy

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • School of Nephrology, University of Milan, Milan, Italy.
  • Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Gianmarco Sabiu

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Sabiu, G., Kasinath, V., Jung, S., Li, X., Tsokos, G. C., & Abdi, R. (2023). Targeted nanotherapy for kidney diseases: a comprehensive review. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac233

Vancouver

Sabiu G, Kasinath V, Jung S, Li X, Tsokos GC, Abdi R. Targeted nanotherapy for kidney diseases: a comprehensive review. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac233

BibTeX
@article{Sabiu2023,
  author = {Sabiu, Gianmarco and Kasinath, Vivek and Jung, Sungwook and Li, Xiaofei and Tsokos, George C and Abdi, Reza},
  title = {Targeted nanotherapy for kidney diseases: a comprehensive review},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfac233}
}
Kostenlos starten →